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Kinase Suppressor of Ras
Is Ceramide-Activated Protein Kinase
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stream effector system (for review, see Hannun, 1996;Sylvie Delikat,* Shariff Bayoumy,*
Jarvis et al., 1996; Spiegel et al., 1996). In this capacity,Xin-Hua Lin,* Subham Basu,*
the sphingomyelin pathway appears to signal pleiotro-Michael McGinley,² Po-Ying Chan-Hui,²
pic functions, inducing proliferation of fibroblasts, differ-Henri Lichenstein,² and Richard Kolesnick*
entiation of promyelocytes, inhibition of the respiratory*Laboratory of Signal Transduction
burst in human neutrophils, survival of T9 glioma cells,Memorial Sloan-Kettering Cancer Center
inhibition of insulin signaling through IRS-1, and apop-New York, New York 10021
tosis in numerous mammalian cell systems, to list a few.²Amgen Inc.
The most comprehensive studies on the involvement of1885 33rd Street
the sphingomyelin pathway in signal transduction haveBoulder, Colorado 80301
been carried out for TNFa. Evidence has been provided
that this pathway initiates both proinflammatory and
apoptotic signaling for TNFa. Kronke and coworkersSummary
used mutants of the cytoplasmic region of the 55 kDa
TNF receptor to demonstrate that specific receptor do-A proline-directed serine/threonine ceramide-acti-
mains link to the different sphingomyelinases (Wieg-vated protein (CAP) kinase mediates transmembrane
mann et al., 1994). A membrane-proximal region linkedsignaling through the sphingomyelin pathway. CAP
the neutral SMase to the extracellular signal±regulatedkinase reportedly initiates proinflammatory TNFa ac-
kinase (ERK) cascade and proinflammatory responses,tion by phosphorylating and activating Raf-1. The
while a carboxyl-terminal region containing the deathpresent studies delineate kinase suppressor of Ras
domain connected to acid SMase.(KSR), identified genetically in Caenorhabditis elegans
A number of direct targets for the signaling action ofand Drosophila, as CAP kinase. Mouse KSR, like CAP
ceramide have now been identified. These include akinase, renatures and autophosphorylates as a 100-
ceramide-activated protein kinase (CAP kinase) (Ma-kDa membrane-bound polypeptide. KSR overexpres-
thias et al., 1991; Joseph et al., 1993; Liu et al., 1994),sion constitutively activates Raf-1. TNFa or ceramide
a ceramide-activated protein phosphatase (Dobrowskyanalogs markedly enhance KSR autophosphorylation
and Hannun, 1992; Hannun, 1996), and the protein ki-and its ability to complex with, phosphorylate, and
nase C isoform z (Lozano et al., 1994; Muller et al., 1995).activate Raf-1. In vitro, low nanomolar concentrations
The most well-defined target for ceramide action is CAP
of natural ceramide stimulate KSR to autophosphory-
kinase. This enzyme is a 97 kDa Ser/Thr protein kinase
late, and transactivate Raf-1. Other lipid second mes-
that is exclusively membrane-associated. CAP kinasesengers were ineffective. Moreover, Thr 269, the Raf-1
belongs to the family of proline-directed Ser/ Thr proteinsite phosphorylated by CAP kinase, is also recognized
kinases (Mathias et al., 1991; Liu et al., 1994), and its
by KSR. Thus, by previously established criteria, KSR
activity is enhanced by treatment of intact cells or iso-
appears to be CAP kinase.
lated membranes with TNFa, IL-1b, ceramide analogs,
and bacterial sphingomyelinases (Spiegel et al., 1996).
Introduction CAP kinase is distinguished from other proline-directed
protein kinases by its preference for X±Thr±Leu±Pro±X,
The sphingomyelin pathway is an ubiquitous, evolution- a somewhat unusual variation of the minimal substrate
arily conserved signaling system initiated by hydrolysis motif recognized by this kinase family (Joseph et al.,
of the plasma membrane phospholipid sphingomyelin to 1993).
generate ceramide (Spiegel at al., 1996). Sphingomyelin Although the full range of the metabolic activities of
degradation is catalyzed by sphingomyelinase (SMase), CAP kinase is as yet unknown, recent studies have sug-
a sphingomyelin-specific form of phospholipase C. Two gested that it signals the proinflammatoryaction of TNFa
forms of sphingomyelinase have been identified based via activating Raf-1 (Yao et al., 1995). Raf-1 was first
on their pH optima. Acid SMase (pH optimum 4.5±5) identified as the normal cellular counterpart of v-raf, the
resides in lysosomes (Kolesnick, 1991) and has also transforming gene of the murine sarcoma virus (Williams
been identified in plasma membrane (Liu and Anderson, and Roberts, 1994). Two other related members of this
1995). Neutral SMase (pH optimum 7.4) is either Mg21- family, A-raf and B-raf, were discovered subsequently
dependent and membrane-bound or cytosolic and cat- (Storm et al., 1990; Stephens et al., 1992). Upon stimula-
ion-independent (Spiegel et al., 1996). Both SMases tion by growth factors, an N-terminal region of cyto-
hydrolyze the same phosphodiester bond to yield cera- plasmic Raf-1 binds to GTP-Ras, and Raf-1 is recruited
mide and phosphocholine. Once generated, ceramide to the plasma membrane, where it is activated by an
acts as second messenger, mediating signaling for a unknown mechanism (Zhang et al., 1993; Leever et al.,
variety of cellular stimuli. 1994). Active Raf-1 phosphorylates and stimulates a
Most, if not all, mammalian cells appear capable of dual specificity kinase MEK1, which in turn phosphory-
signaling through the sphingomyelin pathway. Recep- lates and activates ERKs. Raf-1 mediates signal trans-
tors as distinct as those for IL-1b, progesterone, g-inter- duction induced by numerous growth factors (Rapp,
1991) and some cytokines including TNFa (Belka et al.,feron, and tumor necrosis factor a (TNFa), as well as
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1995). Recently, we reported that CAP kinase mediates feature suggests that mammalian KSR might not even
function as an active protein kinase. None of the isolatedTNF-induced Raf-1 activation at the plasma membrane
of HL-60 cells. CAP kinase formed a complex with Raf-1, KSR cDNAs have yet been expressed and proven to be
active protein kinases. In fact, KSR appeared to act inand phosphorylated Raf-1 in a ceramide- and TNF-
dependent manner (Yao et al., 1995). CAP kinase phos- a kinase-independent manner when cooperating with
oncogenic ras to promote Xenopus oocyte maturationphorylated Raf-1 on Thr268,269, increasing Raf-1 activity
toward MEK1, linking the TNF receptor to proinflamma- and cellular transformation, since it associated with and
activated Raf-1 in vivo, but did not phosphorylate Raf-1tory ERK targets such as phospholipase A2 (Weigmann
et al., 1994; Adam et al., 1996; Schatzman et al., unpub- in vitro (Therrien et al., 1996).
Despite the lack of biochemical information, the avail-lished data).
While activation of Raf-1 involves upstream binding able genetic evidence strongly suggests a similarity be-
tween KSR and CAP kinase. KSR is either upstream orto GTP-Ras, recent studies have identified the existence
of a kinase suppressor of Ras (KSR) (Kornfeld et al., parallel to Raf-1 in genetic screens, is similar in size to
CAP kinase, and contains a putative lipid-binding site.1995; Sundaram and Han, 1995; Therrien et al., 1995).
This putative protein kinase was isolated recently by To evaluate potential similarities, we have compared
KSR with CAP kinase biochemically. Here, we show thatselection and complementation of genetic mutations in
Drosophila and Caenorhabditis elegans (Kornfeld et al., mouse KSR expressed in COS-7 cells, like CAP kinase,
is an active protein kinase of 100 kDa that is exclusively1995; Sundaram and Han, 1995; Therrien et al., 1995).
KSR appeared to function either upstream of Raf or in membrane-bound and acts immediately upstream of
Raf-1. Treatment of intact cells with TNFa or ceramideparallel with Raf in these systems (Downward, 1995).
The predicted size of C. elegans and Drosophila KSR analogs markedly enhanced the ability of KSR to auto-
phosphorylate, as well as to phosphorylate and activatewas about 90 kDa and 115 kDa, respectively, whereas
the size of a murine homolog was about 100 kDa. A Raf-1. Natural ceramide also stimulated these activities
in vitro. Activation of KSR is specific for ceramide, aspartial human cDNA has also been sequenced. The
N-terminal regions of Drosophila and mammalian KSR other lipid second messengers are ineffective. More-
over, the site on Raf-1, Thr268,269, selectively phosphory-contain four conserved domains, CA1±CA4. CA1 is a
domain unique to KSR, CA2 is a putative Src homology lated by CAP kinase, is also recognized by KSR. These
data strongly suggest that KSR is CAP kinase.3 recognition site, CA3 is a cysteine-rich domain with
similarity to the lipid-binding moiety of protein kinase
C, and CA4 is a serine/threonine-rich domain that resem-
Resultsbles the CR2 domain of Raf-1 (Therrien et al., 1995). In
all species, the C-terminal region of KSR contains the
Expression of KSR Leads to Constitutive11 conserved kinase subdomains found in all known
Activation of Raf-1protein kinases. However, KSR lacks the signature se-
Previous investigations (Mathias et al., 1991; Joseph etquences of any specific kinase group, although it is
al., 1993; Liu et al., 1994; Yao et al., 1995) defined CAPdistantly related to the Raf family. KSR is, nonetheless,
kinase as a 97 kDa, membrane-associated, proline-unlikely to be a Raf family member. The N-terminal Ras-
directed, Ser/Thr protein kinase. CAP kinase activity isbinding domain (RBD), which is critical for Raf±Ras inter-
renaturable in an SDS gel and is enhanced by treatmentaction, is absent from KSR. Furthermore, there was no
of intact cells or isolated membranes with ceramideinteraction between Ras and KSR in the yeast two-hy-
analogs. Recently, we showed that CAP kinase is up-brid system (Sundaram and Han, 1995; Therrien et al.,
stream of Raf-1 and that its activity toward Raf-1 can1995). In addition, kinase subdomain VIII, which is impor-
be stimulated by ceramide and TNFa (Yao et al., 1995).tant for substrate recognition, is not conserved between
Phosphorylation of Raf-1 by CAP kinase increases Raf-1KSR and Raf-1, suggesting that these kinases have dif-
activity toward its physiological substrate MEK1. To de-ferent cellular targets. This was confirmed in the yeast
termine if KSR might act similarly to CAP kinase, wetwo-hybrid system, which, as predicted, demonstrated
cloned mouse KSR cDNA into a mammalian expressionstrong interaction between Raf-1 and MEK, but not be-
vector pcDNA 3 and tagged the cDNA at the N terminustween KSR and MEK (Therrien et al., 1995). Whether
with a Flag sequence. After transient expression of thisKSR might be a tyrosine or serine/threonine kinase is
construct in COS-7 cells, we probed both membranealso uncertain. The amino acid sequence YI(L)APE in
and cytosolic fractions with anti-Flag antibody. Assubdomain VIII of KSR from all species resembles that
shown in Figure 1A, a single band of z100 kDa wasof a Ser/Thr kinase rather than a tyrosine kinase, which
detected in the membrane fraction from cellsexpressingusually contains the consensus sequence WXAPE. In
the KSR construct but not the control vector. We nextcontrast, both C. elegans and Drosophila KSR contain
tested whether KSR had protein kinase activity. 5 3 106the HKDLR motif indicative of tyrosine kinases at subdo-
COS-7 cells expressing Flag-tagged KSR were lysedmain VI, while bothmammalian KSR possess the HKDLK
with NP-40 buffer, and KSR was immunoprecipitatedmotif typical of serine/threonine kinases. This implies
with anti-Flag antibody. Activity of KSR was assayedthat the mammalian KSR homologs might represent a
for autophosphorylation after renaturation in an SDS geldistinct subgroup in a KSR superfamily. The mouse and
(Figure 1B). KSR was detected as a single autophos-partial human KSR display another interesting feature
phorylating band of about 100 kDa in lysates from cellsin kinase subdomain II, in which a conserved lysine
expressing KSR but not vector alone. These studiesresidue involved in the phosphotransfer reaction in all
mammalian kinases is substituted with arginine. This indicate that KSR is an active protein kinase.
KSR Is CAP Kinase
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Figure 2. Ceramide Treatment of COS-7 Cells Increases the Ability
of KSR to Autophosphorylate and to Phosphorylate and Activate
Raf-1
(A) COS-7 cells, transfected as in Figure 1A, were incubated for 4 hrFigure 1. Expression of KSR, a 100 kDa, Membrane-Associated,
in serum-free medium and then treated for 10 min with C2 ceramideRenaturable Protein Kinase, Leads to Activation of Raf-1
(Biomol). Cells were lysed with NP-40 lysis buffer, and Flag-tagged
(A) COS-7 cells were transfected with Flag-tagged mouse KSR as
KSR immunoprecipitated and assayed for autophosphorylation indescribed in Experimental Procedures and homogenized at 60 hr
solution as described in Experimental Procedures.KSR is expressedposttransfection. Equal amounts (30 mg) of microsomal membrane
at similar levels in each sample as monitored by Western blot (notand cytosolic protein were resolved by SDS±PAGE, transferred onto
shown). Data represent one of three similar experiments.a PVDF membrane, and probed with anti-Flag antibody.
(B and C) COS-7 cells expressing Flag-tagged KSR were stimulated(B) Flag-tagged KSR, immunoprecipitated from 2 mg of an NP-40
with 1 mM C2 ceramide for 10 min and lysed with NP-40 buffer aslysate of COS-7 cells with an agarose-conjugated anti-Flag anti-
in (A). Flag-tagged KSR was immunoprecipitated and assayed forbody, was resolved by 7.5% SDS±PAGE, renatured, and autophos-
phosphorylation and activation of recombinant Raf-1 as described inphorylated as described previously.
Experimental Procedures. Data represent one of three experiments.(C) COS-7 cells, cotransfected with Flag-tagged Raf-1 and pcDNA3
vector, or Flag-tagged Raf-1 and Flag-tagged KSR or kinase-inac-
tive KSR, were lysed with RIPA buffer at 60 hr posttransfection.
Flag-tagged Raf-1 was immunoprecipitated and incubated with 40 did not support Raf-1 activation. Similar results were
ml of reaction buffer A (40 mM Tris [pH 7.5], 10 mM MgCl2, 30 mM obtained when Raf-1 activity was measuredby reconsti-
NaCl) containing 0.6 mg of kinase-inactive MEK1 (K97M-MKK1), 50
tution of the entire MAP kinase cascade (Figure 1D).mM ATP, and 30 mCi of [g-32P]ATP (3000 Ci/mmol) for 30 min at 228C.
Furthermore, dephosphorylation of immunoprecipitatedThe reaction was stopped with Laemmli buffer and phosphorylated
MEK1 resolved with SDS±PAGE (7.5%) and autoradiography. Some Raf-1 using protein phosphatase 2A blocked Raf-1 sig-
studies used untagged KSR (n 5 4) and yielded identical results. naling in either assay, and rephosphorylation with KSR/
Expression levels of Raf-1 were similar in all samples as monitored CAP kinase restored signaling (not shown). Thus, by
by Western blot (not shown). These data represent one of three
three criteriaÐidentical molecular weight, exclusivesimilar experiments.
membrane-association, and renaturable protein kinase(D) COS-7 cells were cotransfected and Flag-tagged Raf-1 was im-
activity that activates Raf-1ÐKSR appeared highly simi-munoprecipitated as in (C). Raf-1 activity was measured as in (C)
using 1.25 mg of recombinant human MEK1 (Santa Cruz), 0.625 mg lar to CAP kinase.
of recombinant human ERK1 (UBI), and MBP. After 30 min, phos-
phorylated MBP was resolved by 15% SDS±PAGE, prior to autoradi-
ography. It should be noted that KSR/CAP kinase had almost no Activation of KSR by Ceramide
direct effect on MBP phosphorylation (not shown). These data repre- and TNF In Vivo
sent one of three similar experiments.
To provide additional evidence that KSR might be CAP
kinase, the effect of ceramide treatment on activation
of KSR was tested. 2 3 106 COS-7 cells expressingTo determine whether KSR might mimic CAP kinase
in activating Raf-1 in vivo, Flag-tagged Raf-1 and KSR KSR were treated with different doses of the ceramide
analog, C2 ceramide, as indicated in Figure 2A. KSRwere coexpressed. Raf-1 was immunoprecipitated with
anti-Flag antibody, and Raf-1 kinase activity was as- was then immunoprecipitated with anti-Flag antibody
and assayed for autophosphorylation in an immunesayed using kinase-inactive MEK1 (K97M-MKK1) as
substrate. As shown in Figure 1C, a marked increase in complex kinase assay. Similar to what was observed in
the in-gel assay shown in Figure 1B, KSR from restingRaf-dependent MEK1 phosphorylation was detected in
the sample cotransfected with Raf-1 and KSR, as com- cells manifested detectable basal activity. It should be
noted that the exposure time for the autoradiograph inpared to the sample from cells transfected with Raf-1
and control vector. It should be noted that KSR did not Figure 1B was 20 times longer than that in Figure 2A.
Ceramide treatment induced dose-dependent enhance-directly phosphorylate MEK1 (not shown). In contrast
to wild-type KSR, kinase-inactive KSR(D683A/D700A) ment of KSR-autophosphorylating activity. As little as
Cell
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Figure 4. TNF Treatment of COS-7 Cells Activates KSR
Flag-tagged KSR, immunoprecipitated from COS-7 cells treated
with 10 nM TNFa, was assayed for autophosphorylation and the
ability to phosphorylate and activate recombinant Raf-1, as de-
scribed in Experimental Procedures. Data represent one of three
similar experiments.
whether Raf-1 and KSR form a protein complex. For
Figure 3. Ceramide Stimulates KSR to Complex with Raf-1. these studies, lysates from cells expressing Flag-tagged
(A) COS-7 cells, transfected with Flag-tagged KSR or pcDNA3 vector KSR or control vector were immunoprecipitated with
plasmid, were treated with 50 mM C2 ceramide for 5 min and lysed anti-Raf antibody or control beads (protein A±conju-
with NP-40 buffer. Lysates were subjected to 4 hr of immunoprecipi- gated Sepharose beads) and then probed with anti-
tation with anti-Raf-1 antibody. Two controls, KSR and KSR with
Flag antibody. KSR is readily detected in the sampleceramide treatment, received protein A±conjugated Sepharose
expressing KSR and is immunoprecipitated with anti-beads without anti-Raf-1 antibody. KSR complexed to Raf-1 was
Raf-1 antibody, but not with control beads (Figure 3A).resolved by SDS±PAGE and detected by Western blot using anti-
Flag antibody as in Figure 1A. Data represent one of four similar Coimmunoprecipitation of KSR with Raf-1 was signifi-
experiments. cantly enhanced when Raf-1 was immunoprecipitated
(B) COS-7 cells, cotransfected with FLAG-tagged KSR and Raf-1 or from cells treated with 50 mM C2 ceramide. Similarly,
vector and Raf-1, were handled as in (A), except immunoprecipita-
when KSR was immunoprecipitated with anti-Flagtion was performed with anti-Flag antibody and Western blot with
antibody from a sample coexpressing Raf-1 and Flag-anti-Raf-1 antibody. Data represent one of three similar experi-
tagged KSR, Raf-1 was readily detected in the immuno-ments.
precipitated sample (Figure 3B). Again, coimmunopre-
cipitation of Raf-1 with KSR was dramatically enhanced50 nM C2 ceramide induces an increase in KSR activity,
by C2 ceramide treatment. Immunoprecipitated KSRand a maximal 5- to 10-fold effect was achieved with
also bound recombinant Raf-1 in vitro (not shown). A40 mM C2 ceramide. This is the same range of ceramide
similar ceramide-dependent association of Raf-1 withconcentrations previously shown to increase CAP ki-
CAP kinase was previously demonstrated (Yao et al.,nase activity in HL-60 cells (Liu et al., 1994).
1995), further strengthening the notion that KSR is CAPWe next examined the effect of ceramide on KSR
kinase.activity toward recombinant Raf-1 in an immune com-
Previous results indicated that CAP kinase is involvedplex kinase assay. For these studies, KSR, immunopre-
in TNFa-mediated signal transduction and its activitycipitated from control or ceramide-treated cells, was
enhanced by TNF treatment (Liu et al., 1994; Yao etincubated with a recombinant Raf-1 substrate that had
al., 1995). We therefore stimulated 2 3 106 COS-7 cellsbeen coexpressed with Ras and a protein tyrosine ki-
expressing KSR with TNFa (10 nM) and then assayednase Lck in Sf9 insect cells, as previously described
the autophosphorylating activity of KSR, as well as its(Yao et al., 1995). We titrated the amount of the Raf-1
activity to phosphorylate and activate recombinantused in the assay so that in the absence of KSR,
Raf-1, as described in Figure 2. Figure 4 shows that TNFRaf-1 autophosphorylation and Raf-1-dependent MEK1
induced time-dependent enhancement of the autophos-(K97M-MKK1) phosphorylation were not detectable (not
phorylating activity of KSR. Phosphorylation of recom-shown). Under these conditions of limiting substrate,
binant Raf-1, as well as Raf-1 activity toward kinase-minimal phosphorylation of both Raf-1 and MEK1 were
inactive MEK-1 (K97M-MKK1), were also stimulatedvisualized after a 30 min incubation with KSR immuno-
dramatically by TNFa treatment. A maximal effect wasprecipitated from untreated cells (Figures 2B and 2C).
achieved by 20 min of TNFa treatment, which correlatesTreatment of COS-7 cells with C2 ceramide (1 mM) mark-
closely with the time course of the TNF-induced activa-edly enhanced the activity of immunoprecipitated KSR
tion of CAP kinase previously shown in HL-60 cells (Liuto phosphorylate (Figure 2B) and activate Raf-1 (Figure
et al., 1994; Yao et al., 1995). Kinase-inactive KSR from2C). Similar results were obtained using recombinant
TNF-treated cells, however, did not display autophos-human Raf-1 singly expressed in and immunoprecipi-
phorylating or transactivating properties (not shown). Intated from COS-7 cells (not shown).
separate studies, TNFa, like ceramide (see Figure 3),To understand the molecularmechanism of ceramide-
dependent activation of Raf-1 by KSR, we tested induced KSR to complex with Raf-1 (not shown).
KSR Is CAP Kinase
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Figure 5. Ceramide Stimulates KSR Autophosphorylation and KSR-
Dependent Raf-1 Activation In Vitro
(A) Flag-tagged KSR was immunoprecipitated as described in Ex-
perimental Procedures and assayed for autophosphorylation in 40
ml of reaction buffer B containing 10 mM MnCl2, 10 mM ATP, and 30
mCi of [g-32P]ATP (3000 Ci/mmol) for 30 min at 228Cin the presence of
natural ceramide from bovine brain (Avanti) or diluent. Phosphory-
lated KSR was resolved and detected as in Figure 2A. These data
Figure 6. Raf-1 Activation by KSR Requires Thr268,269
represent one of three similar experiments.
(A) KSR was coexpressed with Flag-tagged Raf-1 or vvRaf-1, and(B) Immunoprecipitated Flag-tagged KSR was assayed for activa-
the activity of immunoprecipitatedRaf-1 was measured using K97M-tion of recombinant Raf-1 in vitro using kinase-inactive MEK1
MKK1 as in Figure 1C. The expression levels of Raf-1 and vvRaf-1(K97M-MKK1) as in Experimental Procedures in the presence or
were similar as monitored by Western blot (not shown). These dataabsence of bovine brain ceramide (Avanti). These data represent
represent one of two similar experiments.one of three similar experiments.
(B) Flag-tagged KSR was immunoprecipitated from a lysate of(C) The capacity of wild-type or kinase-inactive KSR to activate
COS-7 cells treated for 20 min with 10 nM TNFa. KSR activity towardrecombinant Raf-1 in vitro was determined as in (B). These data
recombinant human Raf-1 or vvRaf-1 (a gift from Debbie Morrison)represent one of two similar experiments.
was measured using kinase-inactive MEK1 as described in Experi-
mental Procedures. These data represent one of three similarexperi-
ments.
Activation of KSR by Ceramide In Vitro (C) Flag-tagged KSR was assayed with synthetic Raf-1 peptides
Subsequent studies evaluated the direct effect of cera- as described in Experimental Procedures. The wild-type peptide
contains eight potential phosphorylation sites (shown in bold). Sub-mide on KSR activity in vitro. For these studies, KSR
stitution of alanines and glycines for serines and threonines gener-was immunoprecipitated from COS-7 cells and assayed
ated one peptide ( TTLP peptide) containing only two potential phos-for autophosphorylation and activation of Raf-1 in the
phorylation sites (Thr268,269) and another peptide (AALP peptide) with
presence or absence of natural ceramide. As shown in no potential phosphorylation sites. These data represent one of
Figure 5A, autophosphorylation of KSR was enhanced three similar experiments.
in a dose-dependent manner by natural ceramide. As
little as 10 nM natural ceramide was effective, and a
maximal 10-fold effect was achieved with 200 nM. It shown). In contrast to wild-type KSR, kinase-inactive
KSR did not support ceramide-stimulated signaling (Fig-should be noted that the effective concentration range
for natural ceramide is about 100 times lower than the ure 5C). Similar to CAP kinase (Yao et al., 1995), KSR
had no direct effect on MEK or ERK (not shown). Never-range for the synthetic C2 ceramide analog used in vivo.
Other lipids including arachidonic acid, lyso-phospha- theless, in separate studies (n 5 5), ceramide-activated
KSR significantly increased phosphorylation and activa-tidic acid, phorbol 12-myristate 13-acetate, 1,2-diacyl-
glycerol, phosphatidylserine, and phosphatidylcholine tion of ERK1 when added with recombinant Raf-1 and
MEK1 (not shown). Thus, KSR signaling reconstituteshad no effect on activation of KSR (not shown).
Similarly, natural ceramide enhanced KSR activity to- the entire ERK cascade in vitro. Identical results were
obtained using recombinant human Raf-1 immunopre-ward Raf-1 in vitro. As shown in Figure 5B, in the ab-
sence of KSR, Raf-1 activity toward its physiological cipitated from COS-7 cells (not shown).
substrate MEK1 was barely detectable under the condi-
tions of our assay. Addition of KSR induced phosphory- Substitution of Thr268,269 of Raf-1 Blocks
Activation by KSRlation of Raf-1 (not shown) and stimulated Raf-1 tophos-
phorylate MEK1 (Figure 5B). This activity was markedly Previous investigations showed that CAP kinase prefers
the unusual motif ±TLP± (Joseph et al., 1993). Weenhanced by ceramide. The effect of ceramide was not
due to the directactivation of Raf-1, since in theabsence mapped the CAP kinase phosphorylation sites on Raf-1
to a threonine doublet at Thr268 and Thr269 (Yao et al.,of KSR, the activity of Raf-1 was not stimulated by cera-
mide. Furthermore, dephosphorylation of KSR-acti- 1995). Use of synthetic peptides derived from the pri-
mary Raf-1 sequence surrounding Thr268,269 with single orvated Raf-1 using PP2A blocked Raf-1 signaling (not
Cell
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double amino acid substitutions of alanine for threonine
revealed that Thr269 is the primary target for CAP kinase.
Once Thr269 is phosphorylated, CAP kinase then phos-
phorylates Thr268 (Yao et al., 1995).
To define the relevance of Thr268 and Thr269 to activation
of Raf-1 by KSR/CAP kinase, we used Raf-1 substituted
with valine residues at these positions. In contrast to
wild-type Raf-1, vvRaf-1 is not activated when coex-
pressed with KSR in COS-7 cells (Figure 6A). Further-
more, neither TNF nor ceramide treatment activates
vvRaf-1 in COS-7 cells (not shown). However, vvRaf-1,
like wild-type Raf-1, is activated 5±10-fold by EGF and
the phorbol ester 12-0-tetradecanoylphorbol 13-acetate
(TPA) (not shown). Similarly, recombinant vvRaf-1 from
Sf9 cells is neither phosphorylated (not shown) nor acti-
vated in vitro by KSR/CAP kinase (Figure 6B). Identical
results were obtained using wild-type Raf-1 and vvRaf-1
singly expressed in and immunoprecipitated from
COS-7 cells (not shown). Additional studies used Raf-1
preparations with substitutions of valine residues for
either Thr268 or Thr269. When coexpressed, KSR/CAP ki-
nase activated Raf-1(T268V) as effectively as wild-type
Raf-1, whereas Raf-1(T269V) was not activated (not
shown). Thus, Thr269, but not the putative autophosphor-
ylation site Thr268 (Morrison et al., 1993), appears neces-
sary for Raf-1 activation by KSR/CAP kinase.
To further evaluate KSR signaling, we assayed phos-
phorylation of a set of peptides derived from the primary
amino acid sequence of Raf-1. As shown in Figure 6C,
the wild-type Raf peptide, which contains eight potential Figure 7. Ceramide Stimulates KSR Activity toward Raf-1 Peptide
phosphorylation sites, was phosphorylated to the same In Vitro
extent as the mutated Raf peptide containing only Thr268 (A) Immunoprecipitated Flag-tagged KSR was assayed with TTLP
and Thr269 (termed TTLP peptide). Hence, these other or AALP peptides in the presence of 30 nM ceramide (Avanti) or
potential phosphorylation sites are not recognized by diluent (DMSO). Background counts per minute (cpm), derived from
samples incubated with the AALP peptide, which contains no phos-KSR. Furthermore, substitution of a glycine in the TTLP
phorylation sites, represented less than 25% of the untreated totalpeptide in the position corresponding to proline 271 of
and were subtracted from all points. These data represent one ofRaf-1 reduced phosphorylation by 75%. As expected,
three similar experiments.
the control peptide in which all serine and threonine (B) Immunoprecipitated Flag-tagged KSR was assayed with TTLP
residues were substituted with alanine and glycine resi- or AALP peptides in the presence of ceramide or diluent for 45
dues (termed AALP peptide) showed negligible 32P label- min as described in (A). These data represent one of four similar
experiments.ing. These studies indicate that KSR, like CAP kinase,
(C) Immunoprecipitated Flag-tagged KSR was assayed for 20 minrecognizes Thr268/Thr269. It should be noted that identical
as in (A) in the presence of 30 nM lipid second messengers: (AA),results were obtained when phosphorylated peptide
arachidonic acid; (LPA), lyso phosphatidic acid; (PMA), phorbol 12-was resolved by a phosphocellulose paper assay or by
myristate 13-acetate; DAG: 1,2-diacylglycerol. These data represent
reverse-phase high performance liquid chromatog- one of three similar experiments.
raphy. (D) Immunoprecipitated Flag-tagged KSR was assayed for 5 min in
All subsequent studies used the TTLP variant of Raf-1 the presence of 30 nM ceramide as in (A) using 0.3 mM Raf-1 peptide
(TTLP peptide) or an equivalent amount of substrate peptides spe-peptide. To further evaluate the effect of ceramide on
cific for other Ser/Thr protein kinases including cAMP-dependentKSR activity, KSR was incubated with 30 nM natural
protein kinase (PKA), S6 kinase, casein kinase II (CK II), calcium/ceramide in the presence of the TTLP peptide. Figure
calmodulin±dependent protein kinase (CaM kinase II), and protein7A shows that KSR activity toward this Raf-1 peptide
kinase C (PKC). These data represent one of two similar experi-
was enhanced by ceramide in a time-dependent man- ments.
ner. The increase in activity appeared biphasic; a maxi-
mal 8-fold increase (p , 0.05 versus control) was de-
[LPA], phorbol 12-myristate 13-acetate [PMA], and 1,2-tected after 5 min. Ceramide activation of KSR toward
diacylglycerol [DAG]) had no effect on activation of KSRRaf peptide was also dose dependent at 45 min (Figure
in vitro (Figure 7C). Furthermore, recognition of the Raf7B). The maximal effect was achieved with 30 nM natural
peptide substrate by KSR was also specific. Figure 7Dceramide, which correlates closely to the effective con-
shows that KSR, like CAP kinase (Joseph et al., 1993),centrations that activated KSR toward Raf-1 in vitro, as
displayed minimal activity toward substrates recognizedshown in Figure 5B.
by other Ser/ Thr kinases, including cAMP-dependentThe effect of ceramide onthe activation of KSR toward
protein kinase A (PKA), S6 kinase, casein kinase II (CK II),Raf peptide was specific. All other lipid second messen-
calcium/calmodulin±dependent protein kinase II (CaMgers tested at an equimolar concentration (30 nM) (in-
cluding arachidonic acid [AA], lyso-phosphatidic acid kinase II), and protein kinase C (PKC).
KSR Is CAP Kinase
69
Discussion modified products of a single gene or of multiple genes
will require additional investigation. Consistent with this
paradigm, three N-terminal splice variants of humanThe present studies demonstrate that recombinant KSR
displays all of the previously recognized properties of KSR were found (Therrien et al., 1995). The availability
of reagents to study the roles of KSR/CAP kinase inCAP kinase. The molecular size of KSR is virtually identi-
cal to CAP kinase, and KSR renatures in an SDS gel. signal transduction should permit evaluation of these
and other questions in the near future.Furthermore, KSR, like CAP kinase, appears almost ex-
clusively membrane associated. This subcellular local- A unique feature of murine and human KSR is the
substitution of an arginine for the conserved lysine inization is consistent with activation by ceramide, as cer-
amide is quite hydrophobic and, once generated, likely kinase subdomain II. This residue has been shown to
be involved in the phosphotransfer reaction in numerousto remain within membranes. In fact, KSR immunopre-
cipitated from resting cells demonstrates modest basal protein kinases and, in fact, substitution of this lysine
with arginine results in abolition of the catalytic activityactivity, which is acutely enhanced by ceramide stimula-
tion, indicative of signaling function. In addition to acti- of several protein kinases (Hanks et al., 1988). The pres-
ent investigations provide evidence that the lysine invation in vivo by treatment of cells with ceramide ana-
logs, TNFa also stimulated KSR to autophosphorylate this position is not mandatory. Structural elements of
KSR/CAP kinase provide additional clues to its mecha-and transactivate Raf-1. Like CAP kinase, it appears that
the mechanism by which KSR induces Raf-1 activation nism of activation. There is no signal sequence in KSR/
CAP kinase that might permit membrane association.involves the formation of a protein complex and Raf-1
phosphorylation by KSR. Although interaction of KSR/ However, hydropathy plots define the carboxyl terminus
as a highly hydrophobic region that might serve to inter-CAP kinase and Raf-1 may be direct, involvement of an
intermediary protein remains possible. In vitro, cera- act with the membrane. Ceramide, once generated, may
bind to the region CA3, which is homologous to themide also induces KSR to autophosphorylate and to
bind and activate Raf-1. Furthermore, CAP kinase and lipid-binding site of protein kinase C. Consistent with
this proposal, ceramide has been shown to directly acti-KSR recognize the same unusual proline-directed site,
allowing for the development of a simple peptide assay vate the z isoform of protein kinase C (Lozano et al.,
1994; Muller et al., 1995). Preliminary studies suggestfor measuring activity. The fact that other lipid second
messengers, including the structural homolog dihydro- that autophosphorylated KSR/CAP kinase is the active
form toward exogenous substrate (Yao et al., 1995). It isceramide and the backbone lipid sphingosine (not
shown), fail to activate KSR points to a high degree of plausible that once ceramide induces KSR/CAP kinase
autophosphorylation, KSR/CAP kinase becomes capa-specificity for the structure of ceramide in the activation
process. In sum, by every criterion we have previously ble of phosphorylating Raf-1. Ceramide may also play
a direct role in Raf-1 activation since Raf-1, which con-established, KSR appears to be CAP kinase.
The designation of KSR as CAP kinase allows for more tains a putative lipid-binding site in region CR1, has
recently been shown to be a ceramide-binding proteinprecise molecular ordering of transmembrane signaling
events coupling the 55 kDa TNF receptor to proinflam- (Huwiler et al., 1996). In this capacity, ceramide binding
to Raf-1 might function in Raf-1 translocation to thematory signaling via the MAP kinase cascade. The cur-
rently available data suggest that an 11 amino acid do- membrane compartment.
The proposed sequence of events suggests an alter-main (aa 309±319) of the cytoplasmic portion of the TNF
receptor serves as a recognition site for an adaptor native model for Raf-1 activation. The well-established
paradigm for Raf-1 activation through tyrosine kinaseprotein termed factor associated with neutral sphingo-
myelinase activation (FAN) (Adam-Klages et al., 1996). receptors, involving adaptor proteins that contain Src
homology domains and the activation of Ras, does notFAN-binding to the receptor specifically integrates sig-
naling through to neutral sphingomyelinase in the appear to play a role in TNF-induced Raf-1 activation.
In this regard, the 55 kDa TNF receptor is not a tyrosineplasma membrane. Ceramide is thus generated and
stimulates KSR/CAP kinase to complex with and phos- kinase and, hence, would not be expected to link to
the set of adaptor proteins promoting Ras activation.phorylate Raf-1, initiating signaling down the ERK cas-
cade. One result of signaling via this mechanism is the Furthermore, Thr269 comprises a unique recognition site
not previously shown to be involved in Raf-1 activationactivation by ERK of cPLA2 and the release of arachi-
donic acid (Weigmann et al., 1994). by tyrosine kinases. Nevertheless, Ras may play a role in
TNF-induced Raf-1 activation. Preliminary studies showThe involvement of KSR/CAP kinase in signaling of
other TNF-stimulated responses, such as proliferation, that N17Ras blocked KSR/CAP kinase±induced Raf-1
activation in COS-7 cells and that electroporation ofdifferentiation, NFkB activation, and apoptosis, has not
been evaluated. Perhaps CAP kinase utilizes different anti-ras antibody Y13-259 abolished TNF-induced ERK1
activation in HL-60 cells. This information is consistenttargets to effect these distinct cellular responses. Alter-
natively, CAP kinase may represent a family of protein with the genetic data placing KSR downstream of Ras.
Since KSR/CAP kinase does not bind Ras in the yeastkinases, and each member may display a different sub-
strate specificity. In this regard, many mammalian cells two-hybrid assay (Sundaram and Han, 1995; Therrien et
al., 1995), it is likely that KSR/CAP kinase affects Rasshow, in addition to the 100 kDa form, membrane-asso-
ciated, renaturable kinase activities of 90 kDa and 110 action indirectly through its role in modification of Raf-1
function. Whether another mechanism exists by whichkDa that are stimulated by ceramide and TNFa in vivo
(R. K., unpublished data). Whether these three protein tyrosine kinase receptors can also utilize CAP kinase for
signaling through Raf-1 is presently unknown. However,kinases are alternatively spliced or posttranslationally
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into pFlag±cDNA3, generating an in-frame fusion of Flag to the Npreliminary data show that EGF does not activate KSR/
terminus of the mouse KSR gene.CAP kinase in COS-7 cells and that maximal concentra-
Substitutions of alanine residues for two conserved aspartates,tions of EGF and TNF stimulate more than additive Raf-1
D683 and D700, putatively involved in phosphotransfer, were intro-
activation. Furthermore, EGF and TPA activate valine- duced by two separate sets of overlap extension PCR (Ho et al.,
substituted Raf-1 as effectively as wild-type Raf-1. 1989). For initial introduction of the D683A mutation, the mutagenic
forward primer AAA GCG CTC AAG TCC AAG AAT GTC TTC TATThese data suggest that TNF and EGF activate Raf-1
G and reverse primer CTT GGA CTT GAG CGC TTT GTG CAC GATby different mechanisms. It should be noted that prior
GCC TTT TG were used to generate two PCR fragments from Flag±studies showed that dominant-negative Ras N17 had no
KSR with upstream primer CTC CCA TGG ACA TGC TTT CCT CGCeffect on TNF-induced, stress-activated protein kinase
and downstream primer CCA GAT CAA GGC CTC AGC AGG CTG.
(SAPK)/c-Jun kinase (JNK) activation in PC12 and The two PCR fragments were then used as templates to produce a
COS-7 cells (Minden et al., 1994; Coso et al., 1995). contiguous fragment using the same flanking primers. This fragment
was subsequently used as the template for introducing the D700AThus, the upstream elements linking TNF to the ERK
mutation using the mutagenic forward primer ATC ACA GCC TTCand SAPK/JNK cascades are likely to be distinct.
GGG CTG TTT GGG ATC and reverse primer CAG CCC GAA GGCThe present studies define KSR as CAP kinase. This
TGT GAT GAC CAC TTT GCC in two sequential PCR reactions asdesignation will likely impact three distinct areas of cell
above. The final D683A /D700A double mutation PCR fragment was
biologic research. The demonstration of alternative sig- subcloned into Flag±KSR via internal BamHI and SunI restriction
naling mechanisms for activation of Raf-1 should pro- sites.
vide a basis for new investigations into its role in various
Expression of KSR and Raf-1 in COS-7 Cellscellular responses, including inflammation, proliferation,
COS-7 cells were transfected using LipofectAMINE (GIBCO BRL)and the regulation of anti-apoptosis. Furthermore, the
according to the manufacturer's instructions. At 60 hr posttransfec-availability of CAP kinase as a reagent should facilitate
tion, cells were harvested in NP-40 lysis buffer (25 mM Tris [pH 7.5],
studies of mechanisms by which ceramide activates 137 mM NaCl, 10% glycerol, 1% NP-40, 2 mM EDTA, 1 mM PMSF,
cellular targets to initiate transmembrane signaling. 10 mg/ml leupeptin/soybean trypsin inhibitor, 5 mM NaVO4). The
Lastly, the recognition that KSR/CAP kinase is integral homogenate was centrifuged at 6000 3 g for 5 min, the supernatant
collected, and protein content measured using BCA Reagent Ato inflammatory signaling through the TNF receptor pro-
(Pierce). Protein expression was monitored by Western blot as de-vides a foundation for studies into its role in the patho-
scribed ( Yao et al., 1995).genesis of TNF-mediated disease. It may also provide
a biochemical target for pharmacologic manipulation of Immunoprecipitation of KSR and Raf-1
TNF action in vivo, with potential for clinical application. Flag-tagged proteins were quantitatively immunoprecipitated from
the COS-7 lysate using agarose-conjugated anti-Flag antibody (Sci-
entific Imaging Systems) at 48C for 4 hr or overnight. The beads
Experimental Procedures were washed three times with NP-40 lysis buffer and one time with
reaction buffer B (30 mM HEPES [pH 7.4], 5 mM MgCl2, 1 mM DTT )Cell Culture before measuring kinase activity.
COS-7 cells were grown in DMEM medium containing 10% fetal
bovine serum (GIBCO BRL) at 378C in a 5% CO2 atmosphere. Cell KSR Autophosphorylation
number and viability were assessed by trypan blue exclusion
KSR was immunoprecipitated, washed as above, and incubated
analysis.
with 40 ml of reaction buffer B containing 10 mM MnCl2, 10 mM ATP,
and 30 mCi of [g-32P]ATP (3000 Ci/mmol) for 30 min at 228C. The
reaction was stopped by addition of Laemmli buffer. Samples wereConstruction of Mammalian Expression Vectors
resolved by 7.5% SDS±PAGE and autoradiographed.of Raf-1 and KSR
For some studies, KSR was assayed for in-gel autokinase activityConstruction of Flag±Raf
after denaturation and renaturation as described previously (Liu etAn 8 aa Flag epitope tag was introduced at the N terminus of human
al., 1994).Raf-1 in pBluescript (ATCC, Rockville, MD) by the polymerase chain
reaction (PCR) using CGG GGT ACC GCC ACC ATG GAC TAC AAG
Determination of Raf-1 ActivityGAC GAC GAT GAC AAG GAG CAC ATA CAG GGA GCT TGG AAG
Raf-1 was immunoprecipitated and incubated in 40 ml of a reactionas the 59 primer and an internal Raf-1 sequence as the 39 primer
buffer A (40 mM Tris [pH 7.5], 10 mM MgCl2, 30 mM NaCl) containing(GAA GGC AAG CTT CAG GAA C). The 470 bp PCR fragment was
50 mM ATP, 30 mCi of [g-32P]ATP (3000 Ci/mmol), and either 0.6 mgthen exchanged with the native N-terminalRaf-1 sequence by diges-
of kinase-inactive MEK1 (K97M-MKK1; a kind gift of Dr. Natalie Ahn)tion at the flanking KpnI/HindIII sites. The 1.9 kb complete Flag±Raf
or 1.25 mg of recombinant human MEK1 (Santa Cruz), 0.625 mgcoding sequence was subcloned from pBluescript into pcDNA3
recombinant human ERK1 (UBI), and myelin basic protein (MBP).(Invitrogen) using the flanking KpnI/XbaI sites.
After 20±30 min, the reaction was stopped by addition of SDS sam-Raf-1 mutants, substituted with valine residues at positions 268,
ple buffer. Phosphorylated K97M-MKK1 was resolved by 7.5% SDS±269, or both, were generated in Flag±Raf by overlap extension PCR
PAGE, and phosphorylated ERK1 and MBP were resolved by 15%(Ho et al., 1989) using three mutagenic forward primers GTC CAC
SDS±PAGE, prior to autoradiography.ATG GTC AGC GTC ACG CTA CCG GTG GAC AGC AGG ATG, CAC
ATG GTC AGC ACC GTG CTA CCG GTG GAC AGC AGG ATG, and
GTC CAC ATG GTC AGC GTC GTG CTA CCG GTG GAC AGC AGG Phosphorylation and Activation of Raf-1 by KSR In Vitro
Immunoprecipitated KSR was incubated with reaction buffer A con-ATG, respectively, and the upstream and downstream reverse prim-
ers CAG CAG TTT GGC TAT CAG C and CCC CAT GAA AAG CAG taining 0.5 mM ATP and a protein kinase inhibitor cocktail (20 mM
PKC inhibitor peptide [UBI], 2 mM protein kinase A inhibitor peptideAAT G, respectively. All mutant PCR fragments were subcloned into
Flag±Raf via internal BsgI and Eco47III restriction sites. [UBI], and 20 mM R24571 [Sigma]) for 30 min at 228C. To detect
phosphorylation of Raf-1, KSR-bound beads were washed with re-Construction of Flag±KSR
An oligonucleotide containing the Flag sequence, AAG CTT CCA action buffer B and incubated for 30 min with 20 ml of reaction buffer
B containing 10 mM MnCl2, 20 mM ATP, 30 mCi of [g-32P]ATP (3000GCA GCC ATG GAC TAC AAG GAC GAC GAT GAC AAA GCG AAT
TCC, was first cloned into pcDNA3 through HindIII and EcoRI sites Ci/mmol), and recombinant human Raf-1 coexpressed either with
Ras and Lck in Sf9 insect cells (UBI) or with recombinant humanto generate pFlag±cDNA3. A KSR-containing EcoRI fragment was
excised from pMA57 (a kind gift from Dr. Gerald Rubin) and cloned Flag±Raf-1 immunoprecipitated from COS-7 cells.
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To detect activation of Raf-1 in vitro, immunoprecipitated KSR Hannun, Y.A. (1996). Function of ceramide in coordinating cellular
responses to stress. Science 274, 1855±1859.was first incubated with 20 ml of reaction buffer B containing 10 mM
MnCl2, 20 mM ATP, and Raf-1 obtained either from Sf9 or COS-7 Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K., and Pease, L.R.
cells, as above. After 10 min, 20 ml of a reaction mixture containing (1989). Site-directed mutagenesis by overlap extension using the
30 mM HEPES (pH 7.4), 15 mM MgCl2, 60 mM NaCl, 50 mM ATP, polymerase chain reaction. Gene 77, 51±59.
30 mCi of [g-32P]ATP (3000 Ci/mmol) was added, and Raf-1 activity
Huwiler, A., Brunner, J., Hummel, R., Vervoordeldonk, M., Stabel,
was measured as above. It should be noted that when using triply
S., Van den Bosch, H., and Pfeilschifter, J. (1996). Ceramide-binding
transfected Raf-1 to measure Raf-1activity in vitro, we first screened
and activation defines protein kinase c-raf as a ceramide-activated
each batch for activity by reconstituting signaling through the MAP
protein kinase. Proc. Natl. Acad. Sci. USA 93, 6959±6963.
kinase cascade. Once the activity of each batch of Raf-1 was deter-
Joseph, C.K., Byun, H.S., Bittman, R., and Kolesnick, R.N. (1993).mined, we reduced the quantity of Raf-1 used in our assays to a
Substrate recognition by ceramide-activated protein kinase: evi-level 1¤4±1/10 of that used in the screening assay. Routinely, this
dence that kinase activity is proline-directed. J. Biol. Chem. 268,amounted to 1.2 ml of Raf-1. This rendered the effect of Raf-1 barely
20002±20006.detectable and allows for maximal discrimination of the KSR/CAP
Jarvis, W.D., Grant, S., and Kolesnick, R.N. (1996). Ceramide andkinase effect.
the induction of apoptosis. Clin. Cancer Res. 2, 1±6.
Raf Peptide Assay Kolesnick, R.N. (1991). Sphingomyelin and derivatives as cellular
KSR-bound beads were incubated with reaction buffer B plus 10 signals. Prog. Lipid Res. 30, 1±38.
mM MnCl2, 5 mM ATP, and [g-32P]ATP at 228C in the presence of Kornfeld, K., Hom, D.B., and Horvitz, H.R. (1995). The ksr-1 gene
0.3 mM synthetic Raf peptide or substrate peptides specific for other encodes a novel protein kinase involved in Ras-mediated signaling
Ser/Thr protein kinases. Phosphorylated peptides were resolved by in C. elegans. Cell 83, 903±913.
the P81 phosphocellulose paper assay described previously (Ma-
Leever, S.J., Paterson, H.F., and Marshall, C.J. (1994). Requirementthias et al., 1991). A wild-type Raf-1 peptide derived from the amino
for Ras in Raf activation is overcome by targeting Raf to the plasmaacid sequence surrounding Thr268 and Thr269 of Raf-1 (aa 254±278)
membrane. Nature 369, 411±414.contains eight potential phosphorylation sites (shown in bold),
Liu, J., Mathias, S., Yang, Z., and Kolesnick, R.N. (1994). Renatur-RQRSTSTPNVHMVSTTLPVDSRMIE. The amino acid sequences of
ation and TNFa stimulation of a 97 kDa ceramide-activated proteinsubstrate peptides specific for other protein kinases (Joseph et
kinase. J. Biol. Chem. 269, 3047±3052.al., 1993) are: GRGLSLSR (PKA); LSSLRASTSKSGGQK (S6 kinase);
RRREEETEEE (CK II); PLARTLSVAGLPGK (CaM kinase II); and Liu, P., and Anderson, R.G.W. (1995). Compartmentalized produc-
VRKRTLRRL (PKC). The Raf-1 peptides and the substrate peptides tion of ceramide at the cell surface. J. Biol. Chem. 270, 27179±27185.
for S6 kinase, CK II, and CaM kinase were synthesized using an Lozano, J., Berra, E., Municio, M.M., Diaz-Meco, M.T., Dominguez,
Applied Biosystems model 431A synthesizer. Substrate peptides I., Sanz, L., and Moscat, J. (1994). Protein kinase C z isoform is
for PKA and PKC were from Sigma (St. Louis, MO). In some experi- critical for kB-dependent promoter activation by sphingomyelinase.
ments, samples were separated by C18 reverse-phase HPLC (Ma- J. Biol. Chem. 269, 19200±19202.
thias et al., 1991) to verify the results of the filter assay. Virtually
Mathias, S., Dressler, K., and Kolesnick, R.N. (1991). Characteriza-identical results were obtained with both methods.
tion of a ceramide-activated protein kinase: stimulation by tumor
necrosis factor a. Proc. Natl. Acad. Sci. USA 88, 10009±10013.Acknowledgments
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